Titlebook: Smart Algorithms for Multimedia and Imaging; Michael N. Rychagov,Ekaterina V. Tolstaya,Mikhail Book 2021 Springer Nature Switzerland AG 2

新石器时代

书目名称Smart Algorithms for Multimedia and Imaging影响因子(影响力)




书目名称Smart Algorithms for Multimedia and Imaging影响因子(影响力)学科排名




书目名称Smart Algorithms for Multimedia and Imaging网络公开度




书目名称Smart Algorithms for Multimedia and Imaging网络公开度学科排名




书目名称Smart Algorithms for Multimedia and Imaging被引频次




书目名称Smart Algorithms for Multimedia and Imaging被引频次学科排名




书目名称Smart Algorithms for Multimedia and Imaging年度引用




书目名称Smart Algorithms for Multimedia and Imaging年度引用学科排名




书目名称Smart Algorithms for Multimedia and Imaging读者反馈




书目名称Smart Algorithms for Multimedia and Imaging读者反馈学科排名

地名词典

强有力

Aggressive

Ekaterina V. Tolstaya,Viktor V. Buchaent of various forms of liver failure, hepatitis, and acute In recent years, substantial progress has been made in the approaches to diagnosis and treatment of severe liver diseases in the pediatric ICU, from various forms of liver failure and hepatitis to acute and chronic liver disease. New techni

OFF

思考而得

Michael N. Mishourovskyve divergent hepatic outcomes, with those with NAFL having benign course, whereas those with nonalcoholic steatohepatitis (NASH) being at risk for development of cirrhosis, liver failure, and hepatocellular carcinoma. Most patients with NAFLD are asymptomatic and commonly have other metabolic comorb

细微的差异

Sergey Y. Podlesnyynated for hepatitis A and B. Patients with cirrhosis in particular have an increased risk of worsening liver function from influenza or pneumococcal infection and thus should be vaccinated. Cirrhotics should avoid live vaccines if feasible due to the potential risk of developing infection..The major

明确

Xenia Y. Petrova,Valery V. Anisimovsky,Michael N. Rychagovve divergent hepatic outcomes, with those with NAFL having benign course, whereas those with nonalcoholic steatohepatitis (NASH) being at risk for development of cirrhosis, liver failure, and hepatocellular carcinoma. Most patients with NAFLD are asymptomatic and commonly have other metabolic comorb

羽毛长成

Konstantin A. Kryzhanovskiy,Ilia V. Safonove of approximately 300 newborns. Hepatic involvement in CF, called cystic fibrosis liver disease (CFLD), has the third highest mortality rate in CF. Over a third of patients develop liver involvement in form of advanced fibrosis and cirrhosis in their first decade of life. Therefore, an early diagno

inchoate